Viracta Therapeutics, Inc.
VIRXDelisted Jul 10, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001061027
Viracta Therapeutics, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Nov 27, 2024; 32 institutions reported holding it in 13F filings for Q4 2024, worth $583.0K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Viracta Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 50 | 63 | +13 |
| Shares | 9.95M | 13.4M | +3.44M (+34.6%) |
| Value | $92.0M | $151.8M | +$59.8M (+65.0%) |
New holders (27)
Institutions that held Viracta Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
Sold out (14)
Institutions that held Viracta Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Price T Rowe Associates Inc | 510,000 | $4.72M |
| Logos Global Management LP | 470,000 | $4.35M |
| Ikarian Capital, LLC | 155,599 | $1.44M |
| Monashee Investment Management LLC | 84,802 | $784.0K |
| ExodusPoint Capital Management, LP | 60,443 | $559.0K |
| Silverarc Capital Management, LLC | 28,570 | $264.0K |
| HRT Financial LP | 23,826 | $220.0K |
| Capstone Investment Advisors, LLC | 18,977 | $176.0K |
| Boothbay Fund Management, LLC | 17,858 | $165.0K |
| Qube Research & Technologies Ltd | 10,326 | $96.0K |
| Sowell Financial Services LLC | 4,285 | $44.0K |
| Advisor Group Holdings, Inc. | 540 | $5.00K |
| Steward Partners Investment Advisory, LLC | 17 | $157 |
| Valeo Financial Advisors, LLC | 17 | $0 |